FDA Adviser Hopes to Straighten Out U.S. Cannabis Policy. Can He?

If you cannot view this email, please click here.

After Oklahoma, the Cannabis Industry Eagerly Awaits Legalization Action Elsewhere

Attorneys share their reactions to state legislatures considering legalization, what they make of voters rejecting an adult-use market in Oklahoma, and what it all means for federal policy reform. More >>>

A Unified National Cannabis Policy

FDA’s new senior public health adviser Norman Birenbaum talks about the agency’s approach to hemp-derived products and cannabis regulation, and what may come next. More >>>

13 States That Could Legalize Cannabis in 2023

We're rolling out the official CBT crystal ball and taking a shot at which states will enact cannabis reform this year. More >>>

What the Cannabis Industry Can Learn From Top California Brands

The California brands that are gaining consumers’ attention—and dollars—the most point to opportunities that still exist in the world’s largest cannabis market. More >>>

About CBT:
Cannabis Business Times is the most trusted source of actionable intelligence for plant-touching cannabis businesses throughout North America and is producer of the industry-leading Cannabis Conference.